09 Nov NR4A1/3 and HBB as new predictive biomarkers of neoadjuvant responses in breast cancer patients
Posted at 01:27h
in New frontiers in treatment/Precision medicine
ID: 2608
Autores: Fuster, Gemma (0); Carbó, Neus (1,2); Fernandez-Nogueira, Patricia (3,4,5); Castillo, Elena (1,2); Oro, Martí Oro (1,2); Risso, Giorgia (1,2); Pons, Laura (6); Urbizu, Aintzane (6); Ruiz, José Javier (7); Marro, Mónica (7); Arnaldo, Laura (6); Hernández, Laura (6); Felip, Eudald (8); Quiroga, Vanesa (8); Sanz, Carolina (6); Castillo-Gandía, Ana (6); Muñoz-Mármol, Ana Maria (6,9); Loza-Alvarez, Pablo (7); Fernández, Pedro L. (6,9); Fuster, Gemma (1,2,5)
Temática: New frontiers in treatment/Precision medicine
Leer completo